换一批
换一批Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.
第一作者：
Elliott M,Antman
第一单位：
Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. eantman@rics.bwh.harvard.edu
作者：
主题词
急性冠状动脉综合征(Acute Coronary Syndrome);心绞痛, 不稳定型(Angina, Unstable);血管成形术, 气囊, 冠状动脉(Angioplasty, Balloon, Coronary);阿司匹林(Aspirin);综合疗法(Combined Modality Therapy);药物疗法, 联合(Drug Therapy, Combination);出血(Hemorrhage);人类(Humans);Kaplan-Meiers评估(Kaplan-Meier Estimate);心肌梗死(Myocardial Infarction);心肌缺血(Myocardial Ischemia);哌嗪类(Piperazines);血小板聚集抑制剂(Platelet Aggregation Inhibitors);比例危险度模型(Proportional Hazards Models);嘌呤能P2受体拮抗剂(Purinergic P2 Receptor Antagonists);支架(Stents);噻吩类(Thiophenes);噻氯匹定(Ticlopidine)
DOI
10.1016/j.jacc.2008.04.002
PMID
18498956
发布时间
2018-12-01
- 浏览118
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
